IdentifySensors Biologics
PrivateLast Round
Series A
Mar 3, 2025
Est. Valuation
$222.56M
Total Funding Raised
$20M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
IdentifySensors Biologics is a biotechnology company that develops a digital diagnostic platform called Check4® which uses graphene-based electronic biosensors to rapidly detect targeted gene sequences from pathogens and cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors, Health IoT, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IdentifySensors Biologics Comparables
Compare IdentifySensors Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GrapheneDx | 86% | |
| HeMemics Biotechnologies | 77% | |
| Alveo Technologies | 74% |
IdentifySensors Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 3, 2025 | ||||
| Crowdfunding | Jan 9, 2024 | ||||
| Private Placement | Jul 26, 2023 | ||||
| Crowdfunding | Oct 27, 2020 |
IdentifySensors Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purdue Research Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 68% MoM.
- Mar 3, 2025
$20M round completed.
IdentifySensors Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about IdentifySensors Biologics's valuation, stock price, and market status.
Is IdentifySensors Biologics a public or private company?
IdentifySensors Biologics is a private company.
What is the current stock price of IdentifySensors Biologics?
IdentifySensors Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is IdentifySensors Biologics worth (valuation)?
IdentifySensors Biologics's valuation is estimated at $222.6M based on funding round data.
Can I buy IdentifySensors Biologics stock?
IdentifySensors Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was IdentifySensors Biologics's last funding round?
IdentifySensors Biologics's most recent funding round was Series A on January 9, 2024.
Who are the main investors in IdentifySensors Biologics?
Key investors in IdentifySensors Biologics include Purdue Research Foundation.
Will IdentifySensors Biologics IPO soon?
No public IPO plans have been announced for IdentifySensors Biologics.
How can I track IdentifySensors Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IdentifySensors Biologics's secondary market activity and sign up for updates.